WHO joins international collaboration on GMP inspection of API manufacturers, membership criteria established
This article was originally published in SRA
Executive Summary
The World Health Organization has joined the ongoing international collaboration between EU, US and Australian drug regulators on good manufacturing practice inspections of active substance manufacturers1. In addition, clear criteria have been established for new participants to be accepted onto the programme and also to maintain consistent standards among existing participants2.